Direxion mRNA ETF – AMEX:MSGR

Direxion mRNA ETF stock price monthly change

+3.67%
month

Direxion mRNA ETF stock price quarterly change

-11.97%
quarter

Direxion mRNA ETF key metrics

Market Cap
 N/A
Enterprise value
 N/A
P/E
 N/A
EV/Sales
 N/A
EV/EBITDA
 N/A
Price/Sales
 N/A
Price/Book
 N/A
PEG ratio
 N/A
EPS
 N/A
Revenue
 N/A
EBITDA
 N/A
Income
 N/A
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Direxion mRNA ETF stock price history

Direxion mRNA ETF stock forecast

Direxion mRNA ETF financial statements

Direxion mRNA ETF other data

Direxion mRNA ETF
Latest News

Tuesday, 20 December 2022
Zacks Investment Research
Monday, 8 August 2022
Zacks Investment Research

Frequently Asked Questions (FAQ)

  • When is Direxion mRNA ETF's next earnings date?

    Unfortunately, Direxion mRNA ETF's (MSGR) next earnings date is currently unknown.

  • Does Direxion mRNA ETF pay dividends?

    No, Direxion mRNA ETF does not pay dividends.

  • What is Direxion mRNA ETF's stock symbol?

    Direxion mRNA ETF is traded on the AMEX under the ticker symbol "MSGR".

  • What is Direxion mRNA ETF's primary industry?

    Company operates in the Financial Services sector and Asset Management industry.

  • How do i buy shares of Direxion mRNA ETF?

    Shares of Direxion mRNA ETF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • When Direxion mRNA ETF went public?

    Direxion mRNA ETF is publicly traded company for more then 3 years since IPO on 9 Dec 2021.

Direxion mRNA ETF company profile:

Direxion mRNA ETF

Exchange:

AMEX

Full time employees:

0

Industry:

Asset Management

Sector:

Financial Services

The fund, under normal circumstances, invests at least 80% of its assets in the securities that comprise the index or investments with economic characteristics similar to the securities included in the index. The index provides exposure to the performance of companies, publicly listed in the United States, Canada and Europe, that are leading the development and application of messenger RNA (“mRNA”) technology. The fund is non-diversified.


,

CIK: 0001424958
:
: